Huffington Post: Where Are the Scientist-Advocates and Civic-Scientists?

The flattening in support for biomedical research as well as other research fields in the United States over the last decade is having serious consequences for American science and scientists. Ultimately, we need a new generation of scientist-advocates and policy experts if we expect to reverse this trend.
When it comes to scientific research, not all schistosomes are treated equally.
On Tuesday, two of Sabin Vaccine Institute’s senior executives, Dr. Peter Hotez and Dr. Ciro de Quadros, were named among the “Top 50 Global Vaccine Influencers” by Vaccine Nation. Both Dr. Hotez and Dr. de Quadros have made significant contributions in global health throughout their careers and the countless lives they have touched stand as a testament to their vaccine advocacy and development efforts.
In this first study of its kind, Drs. Hotez and Lee measured the health and economic impact of Chagas disease and found that the total economic burden matches or exceeds that of many more well-known diseases such as rotavirus, Lyme disease and cervical cancer. In total, the study estimates that the global economic cost of Chagas disease exceeds USD $7 billion annually.
Heather Ignatius, a senior policy and advocacy officer with PATH’s Advocacy and Public Policy team in Washington, DC, recently wrote about her thoughts on global health and development priorities for the second-term Obama administration and the 113th Congress. Thanks to PATH for allowing us to share her piece. Photo credit: PATH/Mike Wang

Dr. Peter Hotez recently published a new discussion paper in partnership with the Institute of Medicine. It makes recommendations for U.S. Government public support of global health research and development, including R&D for neglected diseases.

Pages

Subscribe to RSS - Sabin Vaccine Development